Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Equity (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Return on Equity data on record, last reported at 0.17% in Q4 2025.

  • For Q4 2025, Return on Equity rose 16.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.17%, up 16.0%, while the annual FY2025 figure was 0.17%, 16.0% up from the prior year.
  • Return on Equity reached 0.17% in Q4 2025 per ORGO's latest filing, up from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.43% in Q2 2021 and bottomed at 0.06% in Q1 2025.
  • Average Return on Equity over 5 years is 0.1%, with a median of 0.05% recorded in 2023.
  • Peak YoY movement for Return on Equity: surged 202bps in 2021, then fell -27bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.29% in 2021, then crashed by -79bps to 0.06% in 2022, then plummeted by -58bps to 0.03% in 2023, then plummeted by -87bps to 0.0% in 2024, then surged by 5170bps to 0.17% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.17% in Q4 2025, 0.0% in Q3 2025, and 0.03% in Q2 2025.